Premier Alternatives

inSoma Bio

Durham, NC · Founded 2018 · Privately Held (backing)

Developer of bioengineered reconstructive biomaterials designed to enable the use of a person's tissue in surgical procedures. inSoma Bio is based in Durham, NC and was founded in 2018. Its last reported valuation was $18.7 million in May 2024. It has raised $7.8 million across 3 recorded rounds; the latest was a $2.7 million seed round in Sep 2025.

Last reported valuation
$18.7M
Oct 2026
Priced at
—
Total raised
$7.8M
Last round
Seed Round
Sep 2025

inSoma Bio key facts

as of Oct 2026
  • Developer of bioengineered reconstructive biomaterials designed to enable the use of a person's tissue in surgical procedures.
  • inSoma Bio is valued at approximately $18.7M as of Oct 2026 (last reported valuation).
  • It has raised $7.8M across 3 recorded rounds; the latest was Seed Round ($2.7M) in Sep 2025.
  • Notable investors include Y Combinator, US National Science Foundation, MedTech Innovator, National Institutes of Health, Makai VC — 23 tracked in total.
  • inSoma Bio has filed 10 Form Ds with the SEC since 2020, most recently May 2024 ($2.7M sold to 16 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$18.7M

inSoma Bio's last reported valuation, May 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of inSoma Bio with a free account
  • ·The complete investor list: 23 names
  • ·Watch inSoma Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

inSoma Bio funding rounds

3 rounds
Sep 2025Seed Round$2.7MSEC filing▮
Apr 2023Seed Round$2.7MSEC filing▮
Aug 2020Seed Round$1.3MSEC filing▮
Full funding history →

inSoma Bio valuation

inSoma Bio's last reported valuation was $18.7 million in May 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has inSoma Bio raised?

inSoma Bio has raised $7.8 million across 3 recorded rounds since 2020. The largest was a $2.7 million seed round in Apr 2023; the most recent was a $2.7 million seed round in Sep 2025.

inSoma Bio has filed 10 Form Ds with the SEC since 2020, most recently in May 2024 ($2.7 million sold to 16 investors).

inSoma Bio investors

23 investors are on record for inSoma Bio, including Y Combinator, US National Science Foundation, MedTech Innovator and National Institutes of Health. By type, the record holds 5 venture capital firms and 1 family office. The seed round in Sep 2025 drew 15 investors.

About inSoma Bio

Developer of bioengineered reconstructive biomaterials designed to enable the use of a person's tissue in surgical procedures. The company offers protein-based scaffolds with thermal responsiveness and genetic engineering for structural support and tissue integration, enabling reconstructive surgeons to provide patients with alternatives to synthetic implants that promote natural tissue repair and adaptability.

Sector
Healthcare
HQ
Durham, NC, United States
Founded
2018
Employees
10
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.